Omega Therapeutics EPS Diluted (Quarterly) Insights

Omega Therapeutics Inc (OMGA)

0.786 +0.01 (+1.29%) USD | NASDAQ | Nov 22, 16:00

0.765 -0.02 (-2.67%) After-Hours: 20:00

EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2020. Upgrade now.

Date	Value
September 30, 2024	-0.30
June 30, 2024	-0.30
March 31, 2024	-0.36
December 31, 2023	-0.36
September 30, 2023	-0.40
June 30, 2023	-0.54
March 31, 2023	-0.50
December 31, 2022	-0.64
September 30, 2022	-0.54
June 30, 2022	-0.54

Date	Value
March 31, 2022	-0.42
December 31, 2021	-0.44
September 30, 2021	-0.57
June 30, 2021	-0.3298
March 31, 2021	-0.4333
December 31, 2020	-0.3041
September 30, 2020	-0.2648
June 30, 2020	-0.2031
March 31, 2020	-0.1741

Earnings per Share Definition

Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.

Read full definition.

EPS Diluted (Quarterly) Range, Past 5 Years

-0.64

Minimum

Dec 2022

-0.1741

Maximum

Mar 2020

-0.401

Average

-0.40

Median

Sep 2023

EPS Diluted (Quarterly) Benchmarks

Moderna Inc	0.03
NovaBay Pharmaceuticals Inc	-0.60
Palatin Technologies Inc	-0.39
iBio Inc	-0.46
Theriva Biologics Inc	-6.81

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly)	-16.44M
Revenue (Quarterly)	2.612M
Total Expenses (Quarterly)	19.03M
Enterprise Value	28.73M
Profit Margin (Quarterly)	-629.6%
Earnings Yield	-167.9%
Normalized Earnings Yield	-167.94